Downregulation of miR-1323 promotes diabetic foot ulcer wound healing by inhibiting ferroptosis via targeting the MFN2/ACSL4 axis

Background Diabetic foot ulcer (DFU) is a common diabetic complication. High-glucose (HG) induces endothelial cell injury, where ferroptosis plays a key role. miR-1323 is elevated in diabetes, but its role in DFU remains unclear. Methods HUVECs were cultured under HG with anti-miR-1323 or Fer-1 trentment. Cell function was assessed by miR-1323 levels, viability, migration, and VEGF. Ferroptosis was determined by iron, MDA, GSH, ROS, LPO, GPX4, SLC7A11, TFR1, and FTH1. MFN2 and ACSL4 expression were also measured. A DFU mouse model was established with local injection of Antag-miR-1323. Wound healing rate, tissue morphology, collagen deposition, angiogenesis, and ferroptosis-related markers were systematically evaluated. Furthermore, dual-luciferase and rescue assays were performed to validate the targeting regulation of miR-1323 on MFN2 and ACSL4. To further verify the upstream–downstream relationship between MFN2 and ACSL4, 2×2 factorial experiments were performed in vitro and in vivo, and iron content, MDA, GSH, cell viability, and GPX4, MFN2, and ACSL4 protein expression were measured. Results miR-1323 was upregulated under HG and in DFU tissues. miR-1323 inhibition suppressed ferroptosis (reduced iron accumulation and oxidative stress, restored GPX4 expression), improved endothelial function, and accelerated wound healing. Mechanistically, miR-1323 directly targeted MFN2, and indirectly upregulated ACSL4 expression by alleviating the inhibitory effect of MFN2 on ACSL4, thereby activating ferroptosis. Knockdown of MFN2 or overexpression of ACSL4 reversed the protective effects of miR-1323 inhibition. Furthermore, 2×2 factorial experiments confirmed that MFN2 negatively regulates ACSL4 to influence ferroptosis in HG-treated HUVECs and DFU mouse wound tissues. Conclusion miR-1323 regulates ferroptosis via the MFN2/ACSL4 axis in HG-induced endothelial dysfunction and DFU. Downregulation of miR-1323 inhibits ferroptosis, improves endothelial function, and promotes wound healing, offering a novel therapeutic target for DFU.

Authors

Institutions

Publication Details

Journal
Regenerative Therapy
Published
2026-11-19
DOI
https://doi.org/10.1016/j.reth.2026.101206
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Downregulation of miR-1323 promotes diabetic foot ulcer wound healing by inhibiting ferroptosis via targeting the MFN2/ACSL4 axis

Wangcong Jiang, Guobing Cheng, Long Chen, Youyao Xu et al.
Regenerative Therapy
Wound Healing and Treatments
article

Downregulation of miR-1323 promotes diabetic foot ulcer wound healing by inhibiting ferroptosis via targeting the MFN2/ACSL4 axis

Wangcong Jiang, Guobing Cheng, Long Chen, Youyao Xu, Jiayu Zhou, Senyan Wu, Zibin Xiao
article en

Abstract

Background Diabetic foot ulcer (DFU) is a common diabetic complication. High-glucose (HG) induces endothelial cell injury, where ferroptosis plays a key role. miR-1323 is elevated in diabetes, but its role in DFU remains unclear. Methods HUVECs were cultured under HG with anti-miR-1323 or Fer-1 trentment. Cell function was assessed by miR-1323 levels, viability, migration, and VEGF. Ferroptosis was determined by iron, MDA, GSH, ROS, LPO, GPX4, SLC7A11, TFR1, and FTH1. MFN2 and ACSL4 expression were also measured. A DFU mouse model was established with local injection of Antag-miR-1323. Wound healing rate, tissue morphology, collagen deposition, angiogenesis, and ferroptosis-related markers were systematically evaluated. Furthermore, dual-luciferase and rescue assays were performed to validate the targeting regulation of miR-1323 on MFN2 and ACSL4. To further verify the upstream–downstream relationship between MFN2 and ACSL4, 2×2 factorial experiments were performed in vitro and in vivo, and iron content, MDA, GSH, cell viability, and GPX4, MFN2, and ACSL4 protein expression were measured. Results miR-1323 was upregulated under HG and in DFU tissues. miR-1323 inhibition suppressed ferroptosis (reduced iron accumulation and oxidative stress, restored GPX4 expression), improved endothelial function, and accelerated wound healing. Mechanistically, miR-1323 directly targeted MFN2, and indirectly upregulated ACSL4 expression by alleviating the inhibitory effect of MFN2 on ACSL4, thereby activating ferroptosis. Knockdown of MFN2 or overexpression of ACSL4 reversed the protective effects of miR-1323 inhibition. Furthermore, 2×2 factorial experiments confirmed that MFN2 negatively regulates ACSL4 to influence ferroptosis in HG-treated HUVECs and DFU mouse wound tissues. Conclusion miR-1323 regulates ferroptosis via the MFN2/ACSL4 axis in HG-induced endothelial dysfunction and DFU. Downregulation of miR-1323 inhibits ferroptosis, improves endothelial function, and promotes wound healing, offering a novel therapeutic target for DFU.

Regenerative TherapyVol. 33
Quzhou City People's Hospital (CN), Quzhou University (CN)
Wound Healing and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon